SWA
LGND icon

Sutton Wealth Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Sutton Wealth Advisors’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-322
Closed -$21.5K – 1217
2022
Q4 		$21.5K Sell
322
-194
-38% -$12.6K 0.01% 669
2022
Q3 		$27.7K Buy
516
+1
+0.2% +$59 0.01% 548
2022
Q2 		$28.6K Hold
515
– – 0.01% 543
2022
Q1 		$36.1K Buy
515
+175
+51% +$12.7K 0.01% 510
2021
Q4 		$32.7K Sell
340
-83
-20% -$7.67K 0.01% 545
2021
Q3 		$36.8K Buy
+423
New +$32.7K 0.01% 493
2018
Q4 		– Sell
-470
Closed -$80.4K – 1164
2018
Q3 		$80.4K Buy
470
+72
+18% +$10.9K 0.05% 220
2018
Q2 		$51.4K Hold
398
– – 0.04% 279
2018
Q1 		$41K Hold
398
– – 0.03% 326
2017
Q4 		$34K Hold
398
– – 0.02% 379
2017
Q3 		$33.8K Hold
398
– – 0.03% 371
2017
Q2 		$30.1K Buy
398
+66
+20% +$4.62K 0.02% 395
2017
Q1 		$21.9K Hold
332
– – 0.02% 489
2016
Q4 		$21K Hold
332
– – 0.02% 476
2016
Q3 		$21.1K Hold
332
– – 0.02% 447
2016
Q2 		$24.7K Hold
332
– – 0.02% 391
2016
Q1 		$22.2K Buy
+332
New +$20.2K 0.02% 413

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sutton Wealth Advisors's LGND Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Ligand Pharmaceuticals (LGND) in Q1 2023, closing a stake of 322 shares — an estimated $21.5K sold.

Sutton Wealth Advisors first reported a position in LGND in Q1 2016 and held it in 17 quarters. The position peaked at $80.4K in Q3 2018. 212 funds tracked by Wall St. Rank hold LGND as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining Ligand Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 322 Ligand Pharmaceuticals shares in Q1 2023, an estimated $21.5K.
  • Sutton Wealth Advisors first reported a position in Ligand Pharmaceuticals in Q1 2016 and held it in 17 quarters.
  • Sutton Wealth Advisors's Ligand Pharmaceuticals position peaked at $80.4K in Q3 2018.
  • 212 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.